Discoveries

  • Vanderbilt University

    Indrayani Waghmare participates in SEC Emerging Scholars Program

    Five Vanderbilt graduate students recently participated in the SEC Networking and Career Fair hosted by the University of Missouri, part of the SEC Emerging Scholars Program for doctoral and postdoctoral scholars announced earlier this year. The program is intended to serve as a pathway and source of mentorship for… Read More

    Nov. 2, 2022

  • Vanderbilt University

    New target for lung fibrosis

    Idiopathic pulmonary fibrosis (IPF) — a chronic, progressive syndrome — is marked by persistent activation and proliferation of fibroblast cells and the pathologic accumulation of extracellular matrix (scar tissue). Most patients die within 3-5 years of diagnosis. Timothy Blackwell, MD, James West, PhD, and colleagues… Read More

    Nov. 1, 2022

  • Vanderbilt University

    Vanderbilt-Ancora partnership advances research for rare form of epilepsy 

    Vanderbilt researchers’ partnership with Ancora Innovation LLC, a Deerfield Management company that supports Vanderbilt University’s innovative life science research, has added an effort to develop therapeutics for a rare form of epilepsy. This is the fourth drug discovery and development program supported through the Ancora-Vanderbilt collaboration. … Read More

    Nov. 1, 2022

  • Antentor Hinton Jr. receives Chan Zuckerberg Initiative grant to increase representation in research

    Antentor Hinton Jr. receives Chan Zuckerberg Initiative grant to increase representation in research

    Antentor Hinton Jr., assistant professor of molecular physiology and biophysics at the School of Medicine Basic Sciences, has been awarded a grant from Chan Zuckerberg Initiative’s Science Diversity Leadership program. The $1.5 million, five-year grant will support his work on “finding organelle… Read More

    Oct. 21, 2022

  • Vanderbilt University

    ACS journal dedicates of 35-year anniversary issue to founding editor Larry Marnett

    In this issue of the 35th volume of Chemical Research in Toxicology (CRT), we share a special collection of science that celebrates the tremendous advances in this period at the intersection of chemistry and toxicology. Throughout the year, every issue of the Journal has borne a 35-year anniversary symbol to… Read More

    Oct. 18, 2022

  • Vanderbilt University

    Vanderbilt’s Monteggia and Rathmell elected to National Academy of Medicine

    Vanderbilt University faculty members have been elected this year to membership in the National Academy of Medicine, a prestigious, non-governmental organization that advises the nation and the world on important aspects of medical science, health care and public health. Monteggia was recruited to Vanderbilt in 2018 to… Read More

    Oct. 17, 2022

  • Vanderbilt University

    Gene tied to childhood epilepsy

    In the mammalian brain, the chief inhibitory neurotransmitter is called GABA. The gene SLC6A1 encodes the GABA transporter GAT1, and in Neurobiology of Disease, Felicia Mermer, Sarah Poliquin, Jing-Qiong Kang, MD, PhD, and colleagues report experiments — in silico, in vitro and in mice-o… Read More

    Oct. 13, 2022

  • Hinton et al receive grant to host underrepresented minorities in STEM conference

    Hinton et al receive grant to host underrepresented minorities in STEM conference

    The Quality Education for Minorities Network, in partnership with Vanderbilt University, Louisiana Tech University, North Dakota State University and Temple University researchers, has been awarded nearly $70,000 in funding from the National Science Foundation to host the Pipelines to Pathways: Humanizing Diversity in STEM Conference. The conference aims to engage… Read More

    Oct. 7, 2022

  • Dr. James Crowe Jr., professor of medicine, in his lab at Medical Research Building IV. Dr. Crowe is the subject of a feature article in the upcoming Winter 2018 issue of Vanderbilt Magazine. Crowe, who is the Ann Scott Carell Professor of Pediatrics, Pathology, Microbiology and Immunology, as well as director of the Vanderbilt Vaccine Center, has spent his career hunting for a universal flu vaccine. He has re-engineered how flu vaccines work and is on the edge of creating a single shot that covers all flu strains. In a new initiative announced in October, he will lead an international team of researchers as they launch clinical trials of his new vaccine.(John Russell/Vanderbilt University)

    Vanderbilt’s Crowe receives the Building the Foundation Award from Research!America

    James Crowe Jr., MD, director of the Vanderbilt Vaccine Center at Vanderbilt University Medical Center, has received the Building the Foundation Award from Research!America, a national biomedical research advocacy organization, for his team’s role in developing human monoclonal antibodies and vaccine candidates against COVID-19. The award, which was announced Oct. 6,… Read More

    Oct. 7, 2022

  • Vanderbilt University

    Skaar et al land grant to build top-line biosafety facility

    Vanderbilt University Medical Center has been awarded a nearly $8 million grant from the National Institutes of Health to construct a state-of-the-art BioSafety Level 3 (BSL3) facility for research involving the COVID-19 virus, anthrax and other dangerous microorganisms. VUMC currently has two BSL3 labs, but they are small, outdated and… Read More

    Oct. 7, 2022